Sun, Dec 21, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Morgan Stanley and Indus launch UCITS III long/short equity fund

Wednesday, January 19, 2011
Opalesque Industry Update – Morgan Stanley (NYSE: MS) announced the launch of a new fund under its Ucits Irish umbrella, FundLogic Alternatives. The new fund will be managed by Indus Capital Partners LLC and will offer access to a long/short equity strategy focused on the Asia Pacific region. This is the fifth Ucits fund that Morgan Stanley has launched to date.

David Armstrong, Managing Director and Global Head of Fund Linked business at Morgan Stanley commented, “Asia offers some of the most exciting investment opportunities for a long/short equity strategy. We are very pleased to launch our first long/short Ucits fund specialized in this region with Indus Capital. Indus has one of the longest track record of alpha generation in the Asia Pacific region. This new fund is an important addition to Morgan Stanley’s rapidly growing Ucits platform.”

Commenting on the launch, Indus Capital said: “Asian markets are inherently inefficient and are therefore an excellent backdrop for long/short strategies. Since we founded Indus in 2000, we have been developing an investment process which we believe can yield positive returns in difficult markets, and strongly positive returns in stock-friendly markets, yielding an attractive return profile over a given cycle. We are delighted to join forces with Morgan Stanley for the launch of our first Ucits fund. We chose Morgan Stanley for the extensive operational and risk management infrastructure the Firm provides through its platform.”

It can offer both Ucits and non-Ucits Funds on a global basis. The platform delivers fund solutions to clients by combining the financial expertise, innovation and resources of Morgan Stanley and offers a range of products including simple Index Funds, Structured Funds and the more recently launched Third Party managers Ucits Funds.

Fund Details:

Fund Name: Indus PacifiChoice Asia Fund
Umbrella Fund: FundLogic Alternatives Plc
Funds domicile: Ireland
Investment Manager: Indus Capital Parners LLC
Promoter: Morgan Stanley & Co International Plc
Dealing : Weekly dealing
Custodian: Northern Trust Fiduciary Services (Ireland) Limited
Administrator: Northern Trust International Fund Administration Services (Ireland) Ltd
Contact : fundlogic-ir@morganstanley.com

(press release)

kb

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und